TRANSPOSAGEN BIOPHARMACEUTICALS, INC. SBIR Phase I Award,
A SBIR Phase I contract was awarded to TRANSPOSAGEN BIOPHARMACEUTICALS, INC. for $99,724.0 USD from the U.S. Department of Health & Human Services.
Is a
Award Amount (USD)
99,724
0
SBIR/STTR Award Recipient
Contract Number (US Government)
1R43RR021289-01
0
Award Phase
Phase I
0
Award Type
SBIR
0
Official Website
Find more entities like TRANSPOSAGEN BIOPHARMACEUTICALS, INC. SBIR Phase I Award,
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
